Headlines from the Proactive Investors UK newsroom. 

Clinical services group hVIVO’s (LON:HVO) experimental vaccine AGS-v PLUS is to undergo a phase 1 safety trial at the University of Maryland school of medicine. The vaccine is designed to protect against mosquito-borne diseases such as Zika and Malaria.

Bushveld Minerals (LON:BMN) remains on track to meet current 2019 production guidance of 2,800 to 2,900 metric tonnes of vanadium. Productivity improvements boosted output in the second quarter by 14% compared to the previous three months.

Immotion (LON:IMMO) has raised £370,000 more from its fund raise yesterday after an over-subscription broker option was exercised. In total, the virtual reality group raised £2.37mln from the option and placing.

Impairments and a weak UK  economy meant Lloyds interim profits and interest income fell in the first half year to June.

Clothes retailer Next has raised its profit forecasts for this year after a strong performance all through May, June and July. Sales in the quarter rose by 3.8%

Takeaway app group Just Eat’s profits slumped by 98% after heavy investment in its delivery service and food.